Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy ACADIA Pharmaceuticals stock
Learn how to easily invest in ACADIA Pharmaceuticals stock.
ACADIA Pharmaceuticals Inc is a biotechnology business based in the US. ACADIA Pharmaceuticals shares (ACAD) are listed on the NASDAQ and all prices are listed in US Dollars. ACADIA Pharmaceuticals employs 500 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in ACADIA Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ACAD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ACADIA Pharmaceuticals stock price (NASDAQ: ACAD)Use our graph to track the performance of ACAD stocks over time.
ACADIA Pharmaceuticals shares at a glance
|Latest market close||$15.12|
|52-week range||$12.24 - $28.06|
|50-day moving average||$17.22|
|200-day moving average||$20.74|
|Wall St. target price||$23.38|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.33|
Buy ACADIA Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ACADIA Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ACADIA Pharmaceuticals price performance over time
|1 week (2022-06-30)||7.31%|
|1 month (2022-06-03)||-15.53%|
|3 months (2022-04-06)||-44.45%|
|6 months (2022-01-04)||-35.99%|
|1 year (2021-07-07)||-36.92%|
|2 years (2020-07-07)||-73.47%|
|3 years (2019-07-05)||27.14|
|5 years (2017-07-06)||28.69|
ACADIA Pharmaceuticals financials
|Revenue TTM||$493.1 million|
|Gross profit TTM||$225.6 million|
|Return on assets TTM||-19.64%|
|Return on equity TTM||-41.79%|
|Market capitalisation||$2.3 billion|
TTM: trailing 12 months
ACADIA Pharmaceuticals share dividends
We're not expecting ACADIA Pharmaceuticals to pay a dividend over the next 12 months.
ACADIA Pharmaceuticals share price volatility
Over the last 12 months, ACADIA Pharmaceuticals's shares have ranged in value from as little as $12.24 up to $28.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ACADIA Pharmaceuticals's is 0.6738. This would suggest that ACADIA Pharmaceuticals's shares are less volatile than average (for this exchange).
ACADIA Pharmaceuticals overview
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. .
ACADIA Pharmaceuticals in the news
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD
Why Acadia Pharmaceuticals Stock Is Crashing Today
Why Acadia Pharma Shares Are Plunging Today
Frequently asked questionsWhat percentage of ACADIA Pharmaceuticals is owned by insiders or institutions?
Currently 0.419% of ACADIA Pharmaceuticals shares are held by insiders and 92.253% by institutions. How many people work for ACADIA Pharmaceuticals?
Latest data suggests 500 work at ACADIA Pharmaceuticals. When does the fiscal year end for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals's fiscal year ends in December. Where is ACADIA Pharmaceuticals based?
ACADIA Pharmaceuticals's address is: 12830 El Camino Real, San Diego, CA, United States, 92130 What is ACADIA Pharmaceuticals's ISIN number?
ACADIA Pharmaceuticals's international securities identification number is: US0042251084 What is ACADIA Pharmaceuticals's CUSIP number?
ACADIA Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 004225108
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert